Search clinical trials for: GB491 Fulvestrant
Total 453 results
-
Genor Biopharma Co., Ltd.RecruitingLocally Advanced or Metastatic Breast CancerChina
-
Genor Biopharma Co., Ltd.Completed
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
Xuanzhu Biopharmaceutical Co., Ltd.Active, not recruitingAdvanced Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Fudan UniversityActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Genor Biopharma Co., Ltd.RecruitingAdvanced Breast CancerChina
-
Zhejiang Cancer HospitalRecruitingBreast Neoplasm FemaleChina
-
European Organisation for Research and Treatment...Breast International GroupTerminatedBreast CancerUnited Kingdom
-
Roswell Park Cancer InstituteCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
M.D. Anderson Cancer CenterBayerActive, not recruitingOvarian Cancer | Endometrial CancerUnited States
-
Genor Biopharma Co., Ltd.Recruiting
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Liaoning Tumor Hospital & InstituteNot yet recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingBreast Cancer | Breast Cancer FemaleChina
-
Novartis PharmaceuticalsRecruiting
-
Sun Yat-sen UniversityRecruiting
-
UNICANCERTerminated
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Roswell Park Cancer InstituteTerminated
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Eli Lilly and CompanyCompletedBreast CancerNetherlands, Spain, Italy, France, Germany
-
Cancer Institute and Hospital, Chinese Academy...UnknownBreast Cancer | HER2-positive Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive, HER2-negative Advanced Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerChina
-
Eagle Pharmaceuticals, Inc.CompletedPharmacokineticsUnited States
-
AstraZenecaCompletedPostmenopausal Women With ER+ HER2- Primary Breast CancerGermany, United Kingdom
-
Tigris PharmaceuticalsTerminated
-
GOG FoundationNovartisRecruitingEndometroid Endometrial CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
Korea University Guro HospitalRecruitingMetastatic Breast CancerKorea, Republic of
-
Kyoto Breast Cancer Research NetworkTerminated
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan
-
University of Wisconsin, MadisonAstraZeneca; University of PittsburghWithdrawnCarcinoma, Non Small Cell Lung
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Fudan UniversityNot yet recruiting
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
Western Regional Medical CenterTerminatedHER2-positive Breast Cancer | ER-positive Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States